Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125124) titled 'A Machine Learning-Based Risk Prediction Model for Immune-Related Cutaneous Adverse Events' on May 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Cutaneous immune-related adverse event
Intervention:
Training Set:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: Training Set:10500;Test Set:4500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317147
Published by HT Digital Content Services with permission from He...